DSGN Q1 2026 Earnings NarrowerThanExpected Loss as Cost Discipline Continues YSS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Stage Continues NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 USEA Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by 116 Mega Matrix Inc MPU Q3 2023 Earnings EPS Misses Amidst No Revenue Disclosure Stock Declines GFL Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh